View Single Post
Old 10-23-2019, 09:36 AM   Nav to Top 
Biohero
Senior Trader
 
Biohero's Avatar
 
Join Date: Jan 2012
Location: Frankfurt
Posts: 298
Favorites: Aapl celg onxx
Rep Power: 116
Reputation: 36
Biohero is on a distinguished road
Default

ADMP= PARTNERDEAL imminent according to management read below ..market cap of $33 million is a big joke for this company could go to over $100 million valuation on good news

https://finance.yahoo.com/news/adami...203000698.html

ZIMHI (naloxone) Injection
On March 14, 2019, Adamis announced that the FDA had accepted the company’s New Drug Application (NDA) for review and provided a target agency action date (PDUFA) of October 31, 2019. The company believes that if approved, ZIMHI could be an important part of the solution to this growing health crisis of opioid overdose. The company is in discussions with several potential partners for ZIMHI with the goal of finalizing a commercial distribution agreement for the U.S. prior to a potential approval.
Biohero is offline   Rate this post Yes | No Reply With Quote